BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28585317)

  • 1. Modified posterior pelvic exenteration for advanced ovarian malignancies: a single-institution study of 35 cases.
    Minar L; Felsinger M; Rovny I; Zlamal F; Bienertova-Vasku J; Jandakova E
    Acta Obstet Gynecol Scand; 2017 Sep; 96(9):1136-1143. PubMed ID: 28585317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Postoperative morbidities after modified posterior pelvic exenteration for ovarian cancer].
    Emin L; Meeus P; Beurrier F; Ferraioli D; Carrabin N; Ray-Coquard I; Treilleux I; Chopin N
    Gynecol Obstet Fertil; 2015 May; 43(5):342-7. PubMed ID: 25899113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of morbidity and survival between primary and interval cytoreductive surgery in patients after modified posterior pelvic exenteration for advanced ovarian cancer.
    Revaux A; Rouzier R; Ballester M; Selle F; Daraï E; Chéreau E
    Int J Gynecol Cancer; 2012 Oct; 22(8):1349-54. PubMed ID: 22954783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
    Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
    Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior pelvic exenteration and retrograde total hysterectomy in patients with locally advanced ovarian cancer: Clinical and functional outcome.
    Berretta R; Marchesi F; Volpi L; Ricotta G; Monica M; Sozzi G; Di Serio M; Mautone D
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):346-50. PubMed ID: 27343313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. En-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer.
    Yildirim Y; Ertas IE; Nayki U; Ulug P; Nayki C; Yilmaz I; Gultekin E; Dogan A; Aykas A; Ulug S; Ozdemir A; Solmaz U
    Eur J Gynaecol Oncol; 2014; 35(4):400-7. PubMed ID: 25118481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic tumor spreading in primary ovarian cancer with modified posterior exenteration.
    Kato K; Nishikimi K; Tate S; Kiyokawa T; Shozu M
    World J Surg Oncol; 2015 Jul; 13():230. PubMed ID: 26228239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of the influence of infection on overall survival rates, following modified posterior pelvic exenteration for advanced ovarian cancer.
    Szymankiewicz M; Dziobek K; Sznajdorwska M; Wicherek L; Dutsch-Wicherek M
    Ginekol Pol; 2018; 89(11):618-626. PubMed ID: 30508214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of mesenteric lymph nodes involvement in patients undergoing posterior pelvic exenteration during radical or supra-radical surgery for advanced ovarian cancer.
    Berretta R; Capozzi VA; Sozzi G; Volpi L; Ceni V; Melpignano M; Giordano G; Marchesi F; Monica M; Di Serio M; Riccò M; Ceccaroni M
    Arch Gynecol Obstet; 2018 Apr; 297(4):997-1004. PubMed ID: 29380107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified posterior pelvic exenteration for ovarian cancer.
    Houvenaeghel G; Gutowski M; Buttarelli M; Cuisenier J; Narducci F; Dalle C; Ferron G; Morice P; Meeus P; Stockle E; Bannier M; Lambaudie E; Rouanet P; Fraisse J; Leblanc E; Dauplat J; Querleu D; Martel P; Castaigne D
    Int J Gynecol Cancer; 2009 Jul; 19(5):968-73. PubMed ID: 19574794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
    Rottoli M; Vallicelli C; Boschi L; Poggioli G
    Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pelvic posterior exenteration in the management of advanced-stage ovarian cancer.
    Tixier H; Fraisse J; Chauffert B; Mayer F; Causeret S; Loustalot C; Deville C; Bonnetain F; Sagot P; Douvier S; Cuisenier J
    Arch Gynecol Obstet; 2010 Mar; 281(3):505-10. PubMed ID: 19847452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified posterior exenteration for ovarian cancer.
    Eisenkop SM; Nalick RH; Teng NN
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):879-85. PubMed ID: 1923216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified posterior pelvic exenteration with pelvic side-wall resection requiring both intestinal and urinary reconstruction during surgery for ovarian cancer.
    Kato K; Omi M; Fusegi A; Takeshima N
    Gynecol Oncol; 2019 Oct; 155(1):172-173. PubMed ID: 31351675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pelvic posterior exenteration with immediate colo-rectal anastomosis: is it justified and feasible in advanced stage ovarian carcinoma?].
    Buttarelli M; Houvenaeghel G; Lelièvre L; Jacquemier J; Guiramand J; Delpero JR
    Ann Chir; 2006 Oct; 131(8):431-6. PubMed ID: 16707093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of pelvic exenteration for locally advanced primary or recurrent non-colorectal pelvic malignancies.
    Ueda T; Koyama F; Nakagawa T; Nakamura S; Nishigori N; Inoue T; Kawasaki K; Obara S; Nakamoto T; Fujii H; Nakajima Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2433-6. PubMed ID: 24394136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator.
    Bristow RE; Montz FJ
    Gynecol Oncol; 2001 Oct; 83(1):39-48. PubMed ID: 11585412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective review of pelvic malignancies undergoing total pelvic exenteration.
    Kuhrt MP; Chokshi RJ; Arrese D; Martin EW
    World J Surg Oncol; 2012 Jun; 10():110. PubMed ID: 22703863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
    Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.